See more : Entrée Resources Ltd. (ERLFF) Income Statement Analysis – Financial Results
Complete financial analysis of Alpha Healthcare Acquisition Corp. (AHACU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alpha Healthcare Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- ROSE MERC.LTD. (ROSEMER.BO) Income Statement Analysis – Financial Results
- Pasupati Spinning & Weaving Mills Limited (PASUSPG.BO) Income Statement Analysis – Financial Results
- Nanofilm Technologies International Limited (MZH.SI) Income Statement Analysis – Financial Results
- Italgas S.p.A. (IG.MI) Income Statement Analysis – Financial Results
- Targeted Microwave Solutions Inc. (TGTMF) Income Statement Analysis – Financial Results
Alpha Healthcare Acquisition Corp. (AHACU)
About Alpha Healthcare Acquisition Corp.
Alpha Healthcare Acquisition Corp. is a blank check company. The company was incorporated in 2020 and is based in New York, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 0.00 | 1.57M | 1.26M | 1.49M | 6.19M |
Cost of Revenue | 76.55M | 8.26M | 49.00K | 8.43M | 75.60M |
Gross Profit | -76.55M | -6.69M | 1.21M | -6.94M | -69.42M |
Gross Profit Ratio | 0.00% | -427.48% | 96.12% | -465.53% | -1,121.97% |
Research & Development | 76.55M | 63.26M | 61.34M | 54.08M | 75.60M |
General & Administrative | 23.39M | 22.88M | 21.13M | 12.01M | 16.27M |
Selling & Marketing | -3.00M | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 20.39M | 22.88M | 21.13M | 12.01M | 16.27M |
Other Expenses | -73.44M | -1.57M | -1.26M | -1.49M | 0.00 |
Operating Expenses | 23.50M | 84.58M | 81.21M | 64.60M | 16.28M |
Cost & Expenses | 100.05M | 84.58M | 81.21M | 64.60M | 91.88M |
Interest Income | 0.00 | 2.63M | 16.00K | 278.00K | 269.00K |
Interest Expense | 1.13M | 6.20M | 4.35M | 2.20M | 2.30M |
Depreciation & Amortization | 7.72M | 8.26M | 8.28M | 8.43M | 6.75M |
EBITDA | -96.46M | 2.49M | -72.97M | -56.25M | -78.94M |
EBITDA Ratio | 0.00% | -10,245.69% | -10,845.61% | -3,753.92% | -1,275.93% |
Operating Income | -100.05M | -84.58M | -81.21M | -64.60M | -85.69M |
Operating Income Ratio | 0.00% | -5,404.35% | -6,429.77% | -4,332.66% | -1,385.02% |
Total Other Income/Expenses | -10.73M | 72.61M | 54.73M | -1.92M | 269.00K |
Income Before Tax | -110.78M | -11.97M | -26.48M | -66.52M | -85.42M |
Income Before Tax Ratio | 0.00% | -764.54% | -2,096.36% | -4,461.70% | -1,380.67% |
Income Tax Expense | 0.00 | -76.18M | -64.01M | 2.20M | 0.00 |
Net Income | -110.78M | 64.22M | 37.54M | -68.73M | -85.42M |
Net Income Ratio | 0.00% | 4,103.45% | 2,971.97% | -4,609.39% | -1,380.67% |
EPS | -1.07 | 0.62 | 0.94 | -5.52 | -4.25 |
EPS Diluted | -1.07 | 0.62 | 0.94 | -5.52 | -4.25 |
Weighted Avg Shares Out | 103.42M | 103.05M | 39.97M | 12.45M | 20.12M |
Weighted Avg Shares Out (Dil) | 103.42M | 103.05M | 39.97M | 12.45M | 20.12M |
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Alpha Healthcare Acquisition Corp. - AHAC
Regenerative Tissue Developer Humacyte Going Public Via SPAC
Alpha Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing November 9, 2020
Source: https://incomestatements.info
Category: Stock Reports